Literature DB >> 12227483

KID syndrome: response to acitretin.

Bijaylaxmi Sahoo1, Sanjeev Handa, Inderjeet Kaur, Bishan Das Radotra, Bhushan Kumar.   

Abstract

KID syndrome is rare. We report a 17-year-old girl who presented with universally ichthyotic red hue on the face, trunk, and extremities along with deafness and keratitis since childhood. She was diagnosed with KID syndrome. Treatment with acitretin cleared the hyperkeratotic ichthyotic lesions with little effect on the cornea or hearing. Acitretin seems to be a promising new treatment in KID syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12227483     DOI: 10.1111/j.1346-8138.2002.tb00315.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  4 in total

1.  Systemic retinoids in the management of ichthyoses and related skin types.

Authors:  John J Digiovanna; Theodora Mauro; Leonard M Milstone; Matthias Schmuth; Jorge R Toro
Journal:  Dermatol Ther       Date:  2013 Jan-Feb       Impact factor: 2.851

2.  Connexin hemichannels influence genetically determined inflammatory and hyperproliferative skin diseases.

Authors:  Noah A Levit; Thomas W White
Journal:  Pharmacol Res       Date:  2015-07-23       Impact factor: 7.658

3.  Consensus recommendations for the use of retinoids in ichthyosis and other disorders of cornification in children and adolescents.

Authors:  Andrea L Zaenglein; Moise L Levy; Nicole S Stefanko; Latanya T Benjamin; Anna L Bruckner; Keith Choate; Brittany G Craiglow; John J DiGiovanna; Lawrence F Eichenfield; Peter Elias; Philip Fleckman; Leslie P Lawley; Richard A Lewis; Anne W Lucky; Erin F Mathes; Leonard M Milstone; Amy S Paller; Sonali S Patel; Dawn H Siegel; Joyce Teng; Sherry A Tanumihardjo; Lauren Thaxton; Mary L Williams
Journal:  Pediatr Dermatol       Date:  2020-11-10       Impact factor: 1.588

4.  Visual impairment reversal with oral acitretin therapy in keratitis-ichthyosis-deafness (KID) syndrome.

Authors:  Christopher M Wolfe; Alexander Davis; Tarek S Shaath; George F Cohen
Journal:  JAAD Case Rep       Date:  2017-11-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.